125 related articles for article (PubMed ID: 37825337)
1. Mistletoe as an Anti-Hemorrhagic.
Indep Pract; 1881 Jul; 2(7):394-395. PubMed ID: 37825337
[No Abstract] [Full Text] [Related]
2. Demonstration of antibodies to the chitin-binding mistletoe lectin (cbML) in tumor patients before and during therapy with an aqueous mistletoe extract.
Klein R; Franz M; Wacker R; Classen K; Scheer R; Von Laue HB; Stoeva S; Voelter W
Eur J Med Res; 2004 Jun; 9(6):316-22. PubMed ID: 15257874
[TBL] [Abstract][Full Text] [Related]
3. Recognition of different antigens of mistletoe extracts by anti-mistletoe lectin antibodies.
Stein GM; Pfüller U; Berg PA
Cancer Lett; 1999 Jan; 135(2):165-70. PubMed ID: 10096425
[TBL] [Abstract][Full Text] [Related]
4. Induction of anti-mistletoe lectin antibodies in relation to different mistletoe-extracts.
Stein GM; Stettin A; Schultze J; Berg PA
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S57-9. PubMed ID: 9179370
[TBL] [Abstract][Full Text] [Related]
5. Mistletoe infestation mediates alteration of the phytohormone profile and anti-oxidative metabolism in bark and wood of its host Pinus sylvestris.
Hu B; Sakakibara H; Takebayashi Y; Peters FS; Schumacher J; Eiblmeier M; Arab L; Kreuzwieser J; Polle A; Rennenberg H
Tree Physiol; 2017 May; 37(5):676-691. PubMed ID: 28338758
[TBL] [Abstract][Full Text] [Related]
6. Triterpenoids amplify anti-tumoral effects of mistletoe extracts on murine B16.f10 melanoma in vivo.
Strüh CM; Jäger S; Kersten A; Schempp CM; Scheffler A; Martin SF
PLoS One; 2013; 8(4):e62168. PubMed ID: 23614029
[TBL] [Abstract][Full Text] [Related]
7. Anti-mistletoe lectin antibodies are produced in patients during therapy with an aqueous mistletoe extract derived from Viscum album L. and neutralize lectin-induced cytotoxicity in vitro.
Stettin A; Schultze JL; Stechemesser E; Berg PA
Klin Wochenschr; 1990 Sep; 68(18):896-900. PubMed ID: 2124308
[TBL] [Abstract][Full Text] [Related]
8. Traditional Uses, Phytochemical Constituents and Ethnopharmacological Properties of Mistletoe from Phoradendron and Viscum Species.
Montoya-Inzunza LA; Heredia JB; Patra JK; Gouda S; Kerry RG; Das G; Gutierrez-Grijalva EP
Comb Chem High Throughput Screen; 2023 Aug; ():. PubMed ID: 37622692
[TBL] [Abstract][Full Text] [Related]
9. Mistletoe-Extract Drugs Stimulate Anti-Cancer Vγ9Vδ2 T Cells.
Ma L; Phalke S; Stévigny C; Souard F; Vermijlen D
Cells; 2020 Jun; 9(6):. PubMed ID: 32604868
[TBL] [Abstract][Full Text] [Related]
10. Analysis of constituents of the eastern Nigeria mistletoe, Loranthus micranthus linn revealed presence of new classes of osteogenic compounds.
Omeje EO; Khan MP; Osadebe PO; Tewari D; Khan MF; Dev K; Maurya R; Chattopadhyay N
J Ethnopharmacol; 2014; 151(1):643-51. PubMed ID: 24269773
[TBL] [Abstract][Full Text] [Related]
11. Effects of aqueous soybean, mistletoe and red clover extracts on activities of adenosine deaminase and xanthine oxidase enzyme.
Namuslu M; Kocaoglu H; Celik HT; Avci A; Devrim E; Genc Y; Gocmen E; Erguder IB; Durak I
Bratisl Lek Listy; 2014; 115(6):367-71. PubMed ID: 25023428
[TBL] [Abstract][Full Text] [Related]
12. Seasonal variations of triterpene acid contents in Viscum album L. on typical host trees of Hyrcanian forests.
Soursouri A; Hosseini SM; Fattahi F
Sci Rep; 2023 Jul; 13(1):11587. PubMed ID: 37463985
[TBL] [Abstract][Full Text] [Related]
13. Anaphylaxis to viscotoxins of mistletoe (Viscum album) extracts.
Bauer C; Oppel T; Ruëff F; Przybilla B
Ann Allergy Asthma Immunol; 2005 Jan; 94(1):86-9. PubMed ID: 15702822
[TBL] [Abstract][Full Text] [Related]
14. Anti-cancer effects of enteric-coated polymers containing mistletoe lectin in murine melanoma cells in vitro and in vivo.
Han SY; Hong CE; Kim HG; Lyu SY
Mol Cell Biochem; 2015 Oct; 408(1-2):73-87. PubMed ID: 26152904
[TBL] [Abstract][Full Text] [Related]
15. Induction of antibodies to viscotoxins A1, A2, A3, and B in tumour patients during therapy with an aqueous mistletoe extract.
Klein R; Classen K; Fischer S; Errenst M; Scheffler A; Stein GM; Scheer R; von Laue HB
Eur J Med Res; 2002 Aug; 7(8):359-67. PubMed ID: 12204844
[TBL] [Abstract][Full Text] [Related]
16. In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individuals.
Klein R; Classen K; Berg PA; Lüdtke R; Werner M; Huber R
Eur J Med Res; 2002 Apr; 7(4):155-63. PubMed ID: 12010650
[TBL] [Abstract][Full Text] [Related]
17. Effect of mistletoe on endometrial stromal cell survival and vascular endothelial growth factor expression in patients with endometriosis.
Moon JM; Chung YJ; Chae B; Kang HJ; Cho HH; Kim JH; Kim MR
Int J Med Sci; 2018; 15(13):1530-1536. PubMed ID: 30443175
[No Abstract] [Full Text] [Related]
18. Effects of mistletoe products on pharmacokinetic drug turnover by inhibition and induction of cytochrome P450 activities.
Schink M; Dehus O
BMC Complement Altern Med; 2017 Dec; 17(1):521. PubMed ID: 29202738
[TBL] [Abstract][Full Text] [Related]
19. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
[TBL] [Abstract][Full Text] [Related]
20. Targeting inflammation in cancer-related-fatigue: a rationale for mistletoe therapy as supportive care in colorectal cancer patients.
Bock PR; Hanisch J; Matthes H; Zänker KS
Inflamm Allergy Drug Targets; 2014; 13(2):105-11. PubMed ID: 24766319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
